GlobeNewswire by notified

[INVNT GROUP]® Expands Global BrandStory Project® Launches INVNT.ATOM™ - Web3 Focused Digital Innovation Division

Share

New York, NY, April 19, 2022 (GLOBE NEWSWIRE) -- [INVNT GROUP] THE GLOBAL BRANDSTORY PROJECT™, is expanding its global presence and capabilities, launching a Web3-focused digital innovation division, INVNT.ATOM to support brands and organizations navigate, activate and create new storytelling opportunities at the digital frontier. The Singapore-based team of strategists, creators, and community-builders specialize in digital-first campaigns, emergent technologies, and engaging brand experiences calibrated for the new era of Web3. 

Our commitment to brand storytelling and innovation is boundless. Strategy, design and technology continues to drive our Global BrandStory Project. We established INVNT.ATOM to support our clients as they explore and leverage the exciting digital revolution of Web3; ensuring they remain relevant and engage with their most important audiences as new storytelling opportunities emerge. We’re thrilled to welcome Elvin Tan, who joins our team to continue the group’s expansion into APAC, reporting to Laura Roberts, Managing Director of [INVNT GROUP] APAC,” said Scott Cullather, President and CEO, [INVNT GROUP]. 

Elvin Tan has been appointed Managing Director of INVNT.ATOM. Tan joins [INVNT GROUP] with 20 years of Asia Pacific executive management experience ranging from early-stage startups to big tech; holding positions at Google, YouTube, and most recently Huawei. Tan was also an advisor for Goopal, a Fintech company powering innovative blockchain projects through investment and incubation. 

Laura Roberts adds, “We’re excited to welcome Elvin who will lead INVNT.ATOM and our world class Web3-focused team across creative, strategy, project management, accounts, and design to our growing [INVNT GROUP] family. I began my journey in this business as the first INVNT team member back in 2008.  In those days we were known solely as INVNT, which grew into the global live brand storytelling agency.  Since then, we have evolved into the Global BrandStory Project, adding Folk Hero, our brand strategy practice, Meaning, our performance and culture consultancy, HEVĒ, our digital content studio, INVNT Higher Ed supporting colleges and universities around the world, and now INVNT.ATOM, our Web3-focused digital innovation division, leading our clients into the future of brand engagement and global community.” 

INVNT.ATOM already counts on a diverse roster of clients and strategic partners launching digital assets and exclusive experiences including: 

  • BZAR - Future of Community: [INVNT GROUP]’s patent pending, decentralized, content led metaverse; established as a marketplace for IRL and digital transactions, NFTs, entertainment, social and gaming experiences.
  • Lamborghini: The world’s first 1:1 NFT supercar auction attached to the last physical Lamborghini Aventador Ultimae Coupé, in collaboration with Steve Aoki, Krista Kim, and RM Sotheby’s. For an exclusive preview of the NFT visit marketplace.bzar.com.
  • BlockTrust: The trusted authority in the NFT marketplace, securely and privately digitizing physical assets, while helping creators and brands own their audience data and revenue.
  • Circles.Life: Australia’s groundbreaking first-ever 3D out-of-home digital experience merging technology and data, turning influencers and consumers into avatars. 
  • DayAway: Positioned to become the #1 online destination for booking one-of-a-kind luxury hotel experiences.  

“I am joining [INVNT GROUP] at a critical time in the strategic evolution of the Global BrandStory Project. With a focus on being the best brand storytelling agency in the world, the launch of INVNT.ATOM couldn’t come at a better time. We live in a rapidly changing and ever-evolving world. More than ever, brands and organizations need to connect with their consumers and audiences, in meaningful, authentic, and engaging ways. That’s what we are here to do at INVNT.ATOM, and I am proud to lead this team into the next great era of brand storytelling, leveraging all things Web3,” said Elvin Tan, Managing Director INVNT.ATOM.

For more information on INVNT.ATOM visit: www.INVNTATOM.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

RESULT OF RIKSBANK REVERSED AUCTIONS SEK MUNICIPAL BONDS24.5.2022 11:30:00 CEST | Press release

AuctionAuction resultsAuction date2022-05-24Maturity2025Tendered volume, SEK mln500 +/- 500Offered volume, SEK mln994Volume bought, SEK mln0Number of bids4Number of accepted bids0 QuarterQuarter 1Quarter 2Quarter 3Quarter 4Offered volume, SEK mln34450000Volume bought, SEK mln0000Number of bids2100Number of accepted bids0000Average yield, %----Lowest accepted yield, %----Highest yield, %----Accepted at lowest yield, %---- QuarterQuarter 1Quarter 2Quarter 3Quarter 4Offered volume, SEK mln150000Volume bought, SEK mln0000Number of bids1000Number of accepted bids0000Average yield, %----Lowest accepted yield, %----Highest yield, %----Accepted at lowest yield, %----

Nexstim Receives an Order for Two NBS Systems from a Finnish University Hospital24.5.2022 11:30:00 CEST | Press release

Press release, Helsinki, 24 May 2022 at 12:30 PM (EEST) Nexstim Receives an Order for Two NBS Systems from a Finnish University Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") has received an order for two NBS 5 systems from a university hospital in Finland. The customer is an experienced user of the Nexstim NBS 4 system, now acquiring the two new systems to replace the old system and to increase capacity. Nexstim’s NBS (Navigated Brain Stimulation) system is used, for example, in planning neurosurgery or radiation therapy after a patient has had a diagnosis of a brain tumor or other disorder. When the lesion is predicted to be close to functional areas of the brain—such as those responsible for speech production and limb movement —the brain maps generated with NBS can be invaluable when deciding the best, personalized treatment option for the patient. These specific NBS systems also include the software of an NBT® (Navigated Brain Therapy) system, allowing the sys

Sweegen Wins Stevia Reb M Patent Lawsuit Against PureCircle24.5.2022 11:04:00 CEST | Press release

Rancho Santa Margarita, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- Sweegen, the global pioneer in wellness ingredient technologies and innovations, announced its victory against PureCircle in a stevia Rebaudioside M (Reb M) patent lawsuit. "Today's judgment vindicates Sweegen and affirms the company's position as an industry leader in innovative sweetener solutions," said Steven Chen, CEO of Sweegen. PureCircle, acquired by Ingredion in 2020, had filed the 2018 lawsuit against Sweegen in the U.S. District Court for the Central District of California, accusing Sweegen of infringing two PureCircle patents covering the manufacture of Reb M. The legal tide turned on PureCircle when Sweegen obtained a summary judgment that both of PureCircle's asserted patents are invalid. Since it is impossible to infringe an invalid patent, the court's invalidation of the asserted patents ends the infringement case against Sweegen at the U.S. District Court. "As a holder of core proprietary technologies of

Notification and Public Disclosure of Transactions by Person Discharging Managerial Responsibilities24.5.2022 11:00:00 CEST | Press release

Company Announcement No. 38/2022 Copenhagen, 24 May 2022 Notification and Public Disclosure of Transactions by Person Discharging Managerial Responsibilities 1. Information on the person discharging managerial responsibilities/person closely associated a) Name Anders Obel 2. Reason for the notification a) Position/title Member of the Board of Directors b) Initial notification/amendment Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Scandinavian Tobacco Group A/S b) LEI code 5299003KG4JS99TRML67 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Identification code Shares DK0060696300 – STG b) Nature of the transaction Sale of shares c) Price(s) and volume(s) Price(s)Volume(s)DKK 147.6 7,

Disclosure of voting rights for Chairman of the Board24.5.2022 10:44:47 CEST | Press release

Oslo, 24 May 2022. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall open the annual general meeting of the Company on 25 May 2022. Mr. Bøhn holds 123,662 shares, representing 0.3 per cent of the share capital of PCI Biotech. Mr. Bøhn has received powers of attorney to represent and vote for 7,234,249 additional shares. In total, Mr. Bøhn will represent and vote for 19.7 per cent of the share capital. A major part of the powers of attorney are without voting instructions. The powers of attorney are only valid at the annual general meeting on 25 May 2022. This information is subject to the disclosure requirements pursuant to section 4 -3, cf. section 5-12 of the Norwegian Securities Trading Act. Contact information: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Ronny Skuggedal, CFO, rs@pcibiotech.no, Mobile: +47 9400 5757